NCT06154239 (STAMP) is a NA clinical trial of DAYE Diagnostic Tampon in Chlamydia, sponsored by Anne's Day Ltd.

Who is sponsoring NCT06154239?

NCT06154239 is sponsored by Anne's Day Ltd.

What drugs are being tested in NCT06154239?

Interventions in NCT06154239: DAYE Diagnostic Tampon, Vaginal self-swab, Clinician vaginal swab.

What condition does NCT06154239 study?

NCT06154239 studies Chlamydia, Gonorrhea, Bacterial Vaginosis, Human Papilloma Virus.

Is NCT06154239 still recruiting?

NCT06154239 is currently completed. Last updated 31 July 2025.

Last reviewed 2025-07-31 · How we verify

NCT06154239: STAMP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Screening With Tampons: Evaluating Diagnostic Accuracy and HPV and Assessing Participant Views

Completed NA Last updated 31 July 2025

What this trial tests

NA trial testing DAYE Diagnostic Tampon in Chlamydia in 617 participants. Completed in 18 July 2025.

Timeline

15 January 2024

Primary endpoint
18 July 2025

18 July 2025

Quick facts

Lead sponsor	Anne's Day Ltd
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	617
Start date	15 January 2024
Primary completion	18 July 2025
Estimated completion	18 July 2025
Sites	1 location across United Kingdom

Drugs / interventions tested

DAYE Diagnostic Tampon
Vaginal self-swab
Clinician vaginal swab

Conditions studied

Chlamydia — all drugs for Chlamydia →
Gonorrhea — all drugs for Gonorrhea →
Bacterial Vaginosis — all drugs for Bacterial Vaginosis →
Human Papilloma Virus — all drugs for Human Papilloma Virus →

Sponsor

Anne's Day Ltd

Who can join

Adults 25 to 65, female only, with Chlamydia or Gonorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diagnostic trial comparing the diagnostic accuracy of the DAYE Diagnostic Tampon (DDT) with a vaginal swab (self-collected and clinician taken).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chlamydia

Currently open trials in the same condition.

NCT06738407 — Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections · Phase 4 · recruiting
NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
NCT07397403 — The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand. · Phase 4 · recruiting
NCT06951438 — Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortio · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06154239 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Anne's Day Ltd
Last refreshed: 31 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06154239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing